Aquestive Therapeutics, Inc.
NASDAQ:AQST
3.52 (USD) • At close December 27, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Aquestive Therapeutics, Inc. |
Symbool | AQST |
Munteenheid | USD |
Prijs | 3.52 |
Beurswaarde | 320,947,264 |
Dividendpercentage | 0% |
52-weken bereik | 1.95 - 6.23 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Daniel Barber |
Website | https://www.aquestive.com |
An error occurred while fetching data.
Over Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)